DCGI mandates adherence to BIS standards for medical devices, strengthening of testing protocols

  • The directive follows reports of several instances where medical devices were not tested according to established norms, potentially compromising product quality and posing health risks.

Priyanka Sharma
First Published30 May 2024
Rajeev Raghuvanshi, Drugs Controller General of India.
Rajeev Raghuvanshi, Drugs Controller General of India.

New Delhi: The Drugs Controller General of India (DCGI), Rajeev Raghuvanshi, has mandated that medical device manufacturers and in-vitro diagnostic (IVD) testing laboratories comply with the Bureau of Indian Standards (BIS) for product testing.

This directive follows reports of several instances where medical devices were not tested according to established norms, potentially compromising product quality and posing health risks.

Also read | DCGI orders withdrawal of Olaparib for select cancer patients

In a communiqué to medical testing laboratories registered with the Central Drugs Standards Control Organization (CDSCO), the DCGI noted that medical devices with available BIS standards were not being tested in accordance with the guidelines.

Compliance Measures

“It may be ensured that the samples of the medical devices comply with the BIS standards for quality and performance, and accordingly the medical devices shall be tested with respect to the requirements as prescribed in the BIS standards.” The directive was reviewed by Mint.

However, considering that approximately 6,000 medical devices are in use for various medical procedures in India, but only around 1,500 BIS standards are currently available, the ministry of health and family welfare has authorized all stakeholders to also evaluate products under the Medical Device Rules (MDR), 2017. 

Also read |  Top drug regulator seeks detailed report of antibiotics in India

"If no BIS standards are available, then only other standards of the MDR may be applied,” it said. The move seeks to enhance the quality, safety, and performance of medical devices and IVDs, as well as strengthen the pan-India testing infrastructure, it added. 

India heavily relies on imported medical devices, which account for 80% of its supplies. Importing, manufacturing, or marketing of these devices requires a licence.

Aligning Testing Standards

The CDSCO, through the Pharmacopoeia Commission, has set its own testing standards aligned with World Health Organization (WHO) norms, with MDR serving as a compliance checklist for manufacturers. In cases where BIS or MDR standards are not available, testing may conform with standards established by the International Organization for Standardization (ISO), and the International Electrotechnical Commission (IEC).

Safety: Top Priority

Industry experts welcomed the move. “BIS testing norms play a crucial role in ensuring the quality and safety of medical devices. These standards would ensure rigorous testing and evaluation, which guarantees their compliance with national safety and performance requirements," said Jatin Mahajan, secretary, Association of Diagnostic Manufacturers of India. 

Also read | DCGI asks for strict reporting of side-effects related to medical devices

"Adherence to BIS norms not only instills the trust of healthcare providers and patients in the reliability of the devices, but also promotes harmonization of industry standards. Additionally, they help mitigate risks associated with the use of medical devices, thereby safeguarding public health and enhancing India's healthcare infrastructure,” he added. 

Conforming to Standards

According to Rajiv Nath, forum coordinator at the Association of Indian Manufacturers of Medical Devices (AiMeD), licensed manufacturers, claiming to adhere to the BIS standards, must exhibit conformity by getting their products tested at National Accreditation Board for Testing and Calibration Laboratories (NABL)-accredited labs. 

Additionally, they could set up in-house laboratories, which are accredited specifically for BIS standards, and publish the in-house test results. “Just any accreditation claim to some other product testing standards will not do.” 

Also read |  Rampant fakes of lifesaving drugs found in Delhi, Jharkhand

“Medical devices are constantly undergoing change and innovation so it may not be possible for every product to have an existing BIS or ISO product standards, hence the MDR 17 permits manufacturers to lay down their own product specifications or joint industry standards," Nath explained. 

"But whatever they claim, they need to demonstrate compliance by sampling testing as part of a conformity assessment and risk management framework to ensure consistent quality for assuring patients' safety.”

Queries sent to a health ministry spokesperson remained unanswered till press time.


Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.MoreLess
HomeNewsIndiaDCGI mandates adherence to BIS standards for medical devices, strengthening of testing protocols

Most Active Stocks

Tata Steel

10:29 AM | 12 JUN 2024
0.9 (0.5%)

Indian Oil Corporation

10:27 AM | 12 JUN 2024
1.1 (0.66%)

Tata Power

10:29 AM | 12 JUN 2024
1.1 (0.25%)

Tata Motors

10:26 AM | 12 JUN 2024
1.5 (0.15%)
More Active Stocks

Market Snapshot

  • Top Gainers
  • Top Losers
  • 52 Week High

Sunteck Realty

10:20 AM | 12 JUN 2024
50.65 (9.59%)

Max Healthcare Institute

09:59 AM | 12 JUN 2024
68.1 (8.49%)


10:28 AM | 12 JUN 2024
2.61 (6.9%)

Amber Enterprises India

10:22 AM | 12 JUN 2024
257.5 (6.69%)
More from Top Gainers

Recommended For You

    More Recommendations

    Gold Prices

    • 24K
    • 22K

    Fuel Price

    • Petrol
    • Diesel
    New Delhi
    HomeMarketsPremiumInstant LoanGet App